News Radio KOTA
    • Sample Page
Sciwind Biosciences Announces Ecnoglutide Injection Approved by China’s National Medical Products Administration (NMPA) for Chronic Weight Management

Author: Epoint Healthcare

Posted Date:

March 6, 2026
  • Sciwind Biosciences Announces Ecnoglutide Injection Approved by China’s National Medical Products Administration (NMPA) for Chronic Weight Management

    Epoint Healthcare
    March 6, 2026
  • Sciwind Biosciences Partners with Pfizer China to Commercialize its Biased GLP-1 in China

    Epoint Healthcare
    February 24, 2026